LifeWealth Investments LLC Purchases New Shares in Kimberly-Clark Co. (NYSE:KMB)

LifeWealth Investments LLC purchased a new position in shares of Kimberly-Clark Co. (NYSE:KMB - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,039 shares of the company's stock, valued at approximately $267,000.

Other hedge funds have also made changes to their positions in the company. Migdal Insurance & Financial Holdings Ltd. acquired a new stake in Kimberly-Clark in the fourth quarter valued at approximately $25,000. Marshall Investment Management LLC purchased a new stake in shares of Kimberly-Clark during the 4th quarter worth $25,000. Minot DeBlois Advisors LLC purchased a new stake in shares of Kimberly-Clark during the 4th quarter worth $29,000. Golden State Wealth Management LLC acquired a new position in shares of Kimberly-Clark during the 4th quarter worth $32,000. Finally, Strategic Financial Concepts LLC acquired a new position in shares of Kimberly-Clark during the 4th quarter worth $33,000. Institutional investors and hedge funds own 76.29% of the company's stock.

Kimberly-Clark Trading Up 0.8%

Kimberly-Clark stock traded up $1.11 during mid-day trading on Thursday, hitting $143.79. The stock had a trading volume of 1,716,174 shares, compared to its average volume of 2,184,999. The stock has a 50-day simple moving average of $137.40 and a two-hundred day simple moving average of $135.18. The company has a current ratio of 0.80, a quick ratio of 0.54 and a debt-to-equity ratio of 7.05. The stock has a market capitalization of $47.71 billion, a PE ratio of 19.04, a P/E/G ratio of 4.46 and a beta of 0.35. Kimberly-Clark Co. has a 12 month low of $124.10 and a 12 month high of $150.45.

Kimberly-Clark (NYSE:KMB - Get Free Report) last released its earnings results on Tuesday, April 22nd. The company reported $1.93 EPS for the quarter, topping analysts' consensus estimates of $1.89 by $0.04. Kimberly-Clark had a net margin of 12.69% and a return on equity of 201.43%. The firm had revenue of $4.84 billion during the quarter, compared to analyst estimates of $4.90 billion. During the same quarter in the previous year, the business earned $2.01 EPS. As a group, sell-side analysts forecast that Kimberly-Clark Co. will post 7.5 EPS for the current year.

Kimberly-Clark Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 2nd. Stockholders of record on Friday, June 6th will be given a dividend of $1.26 per share. The ex-dividend date of this dividend is Friday, June 6th. This represents a $5.04 dividend on an annualized basis and a dividend yield of 3.51%. Kimberly-Clark's dividend payout ratio is 68.66%.

Insider Activity

In other news, insider Katy Chen sold 740 shares of Kimberly-Clark stock in a transaction dated Friday, May 2nd. The stock was sold at an average price of $129.70, for a total transaction of $95,978.00. Following the transaction, the insider now owns 3,997 shares in the company, valued at $518,410.90. The trade was a 15.62% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Andrew Drexler sold 10,838 shares of Kimberly-Clark stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $141.00, for a total transaction of $1,528,158.00. Following the completion of the sale, the vice president now owns 7,720 shares in the company, valued at $1,088,520. This trade represents a 58.40% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 13,372 shares of company stock valued at $1,858,684 in the last quarter. Company insiders own 0.64% of the company's stock.

Analyst Ratings Changes

KMB has been the subject of a number of research analyst reports. UBS Group upped their price objective on shares of Kimberly-Clark from $134.00 to $146.00 and gave the company a "neutral" rating in a research note on Thursday, April 17th. Wells Fargo & Company boosted their target price on Kimberly-Clark from $130.00 to $140.00 and gave the stock an "equal weight" rating in a report on Friday, March 28th. Evercore ISI decreased their target price on Kimberly-Clark from $168.00 to $155.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Wall Street Zen cut Kimberly-Clark from a "buy" rating to a "hold" rating in a report on Thursday, April 24th. Finally, Royal Bank of Canada cut their target price on Kimberly-Clark from $165.00 to $162.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, Kimberly-Clark presently has a consensus rating of "Hold" and an average target price of $145.08.

Kimberly-Clark Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.